Exploring the feasibility of discontinuing oral anticoagulant therapy in post-ablation atrial fibrillation patients with low stroke risk: a conceptual inquiry

1 April 2025 (08:00 - 14:15)

Organised by:

Abstract

Sign in to view the resources

About the speaker

Doctor Utz Richter

MVZ am Kuechwald, Chemnitz (Germany)

139 More presentations in this session

Presentation thumbnail

The relationship between left atrial electroanatomical voltage mapping and CMR-based fibrosis for enhanced preplanning in atrial fibrillation ablation

Doctor Z. Dadon (Jerusalem, IL)

Abstract Slides Video

Presentation thumbnail

Cardiac sympathetic denervation for different cardiovascular indications - the experience of two referral centers

Doctor A. Zienciuk-Krajka (Gdansk, PL)

Presentation thumbnail

Practicing physicians perception of feasibility and usefulness of quality indicators of treatment for atrial fibrillation

Doctor J. Simic (Belgrade, RS)

Abstract Slides Video

Presentation thumbnail

Risk of left atrial thrombus in patients undergoing catheter ablation for atrial fibrillation and atrial flutter

Assistant Professor F. Guerra (Ancona, IT)

Abstract Slides Video

Presentation thumbnail

Clustering analysis of left atrial smax patterns: predicting atrial fibrillation termination and associations with key clinical factors

Mr J. Huh (Seoul, KR)

Abstract Slides

Access the full session

Session thumbnail

Poster session 3: clinical management of arrhythmias

The Event

Event poster

EHRA 2025

1 April 2025 08:00 CET

You may be interested in

Congress Session

Treatment strategies for atrial fibrillation in heart failure

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

Congress Session

EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources